학술논문
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
Document Type
Article
Author
Sourris, K.C.; Kantharidis, P.; Mohan, M.; Rosado, C.J.; Jandeleit-Dahm, K.; Cooper, M.E.; Coughlan, M.T.; Ding, Y.; Penfold, S.A.; Haase, C.; Maxwell, S.S.; El-Osta, A.; Al-sharea, A.; Xu, Y.; Murphy, A.J.; Forbes, J.M.; Crawford, S.; Ramm, G.; Harcourt, B.E.; Advani, A.; Timmermann, D.B.; Knudsen, L.B.; Karihaloo, A.; Drucker, D.J.
Source
In: Kidney International . (Kidney International, January 2024, 105(1):132-149)
Subject
Language
English
ISSN
15231755
00852538
00852538